Three-dimensional coronary magnetic resonance angiography with injection of extracellular contrast medium

Investigative Radiology

Volumn 34, Issue 8, 1999, Pages 503-508

  Sakuma, Hajime ^a   Goto, Miwako ^a   Nomura, Yoshiyuki ^a   Kato, Noriyuki ^a   Takeda, Kan ^a   Higgins, Charles B ^b  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contrast medium coronary vessels; Coronary artery disease; Magnetic resonance angiography

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE;

ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY ANOMALY; DIAGNOSTIC VALUE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; THREE DIMENSIONAL IMAGING;

EID: 0032786767     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199908000-00002     Document Type: Article

References (17)

1. Wang Y, Rossman PJ, Grimm RC, Riederer SJ, Ehman RL. Navigator-echo-based real-time respiratory gating and triggering for reduction of respiration effects in three-dimensional coronary MR angiography. Radiology 1996;198:55-60.
2. Post JC, van Rossum AC, Hofman MB, et al. Three-dimensional respiratory-gated MR angiography of coronary arteries: comparison with conventional coronary angiography. AJR 1996;166:1399-1404.
3. Li D, Kaushikkar S, Haacke EM. Coronary arteries: Three-dimensional MR imaging with retrospective respiratory gating. Radiology 1996;201:857-863.
4. Muller MF, Fleisch M, Kroeker R, et al. Proximal coronary artery stenosis: Three-dimensional MRI with fat saturation and navigator echo. J Magn Reson Imaging 1997;7:644-651.
5. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994; 191:155-164.
6. Prince MR, Narasimham DL, Jacoby WT, et al. Three-dimensional gadolinium-enhanced MR angiography of the thoracic aorta. AJR 1996;166:1387-1397.
7. Bourne MW, Margerun L. Hylton N, et al. Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body. J Magn Reson Imaging 1996;6:305-310.
8. Stillman AE, Wilke N, Li D, Haacke M, McLachlan S. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: Studies in human patients. J Comp Assist Tomogr 1996;20:51-55.
9. Li D, Zheng J, Weinmann HJ, et al. Comparison of intravascular and extravascular contrast agents in coronary artery imaging [abstr]. In: Proceedings of International Society for Magnetic Resonance in Medicine 1998;17.
10. Li D, Dolan RC, Walovitch RC. Lauffer RB. Three-dimensional MR imaging of coronary arteries using an intravascular contrast agent. Magn Reson Med 1998;39:1014-1018.
11. Goldfarb JW, Edelman RR. Coronary arteries: Breath-hold gadolinium-enhanced three-dimensional MR angiography. Radiology 1998; 206:830-834.
12. Oshinski JN, Hofland L, Mukundan S Jr, Dixon WT, Parks WJ, Pettigrew RI. Two-dimensional coronary MR angiography without breath holding. Radiology 1996;201:737-743.
13. Post JC, van Rossum AC, Bronzwaer JGF, et al. Magnetic resonance angiography of anomalous coronary arteries: A new gold standard for delineating the proximal course? Circulation 1995;92:3163-3171.
14. McConnell MV, Ganz P, Selwyn AP, Li W, Edelman RR, Manning WJ. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation 1995;92:58-62.
15. Manning WJ, Li W, Cohen SI, Johnson RG, Edelman RR. Improved definition of anomalous left coronary artery by magnetic resonance coronary angiography. Am Heart J 1995;130:615-617.
16. Duerinckx AJ, Troutman B, Allada V, Kim D. Coronary MR angiography in Kawasaki disease. AJR 1997;168:114-116.
17. Hofman MB, Wickline SA, Lorenz CH. Quantification of in-plane motion of the coronary arteries during the cardiac cycle: Implication for acquisition window duration for MR flow quantification. J Magn Reson Imaging 1998;8:568-576.